Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2012,NCI,5R01CA142838-03,,Role of redox state in ovarian cancer response to cisplatin,"DANIEL, LARRY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$292,963"
Ovarian Cancer,2012,NCI,5R01CA131407-05,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$335,374"
Ovarian Cancer,2012,NCI,5R01CA077429-13,,Basis for Lymphomagenesis in Akt2 Transgenic Mice,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$410,451"
Ovarian Cancer,2012,NCI,5R01CA104996-08,,Promoting Tumor Immunity by Cross-linking B7-DC,"PEASE, LARRY",MAYO CLINIC,MN,"$239,311"
Ovarian Cancer,2012,NCI,5R01CA103937-08,,Molecular Diagnostics for Malignant Effusion,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$328,003"
Ovarian Cancer,2012,NCI,5R01CA144057-08,,Evaluation of Vectors based on group B adenoviruses,"LIEBER, ANDRE",UNIVERSITY OF WASHINGTON,WA,"$313,989"
Ovarian Cancer,2012,NCI,5R01CA129927-05,,Discovery of Gene Expression Signatures in Cancer Stroma,"WEST, ROBERT",STANFORD UNIVERSITY,CA,"$378,263"
Ovarian Cancer,2012,NCI,5R01CA124951-03,,Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy,"FANG, BINGLIANG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$309,964"
Ovarian Cancer,2012,NCI,1R41CA162648-01,,Development of Novel Agents Targeting Genome Stability and Maintenance for Treati,"TURCHI, JOHN","NERX BIOSCIENCES, INC.",IN,"$229,680"
Ovarian Cancer,2012,NCI,5R01CA079716-13,,Ovarian Cancer: Epithelial Dedifferentiation,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$326,412"
Ovarian Cancer,2012,NCI,5R01CA142776-03,,"The role of microRNA, mir-30d, in the initiation and progression of cancer","ZHANG, LIN",UNIVERSITY OF PENNSYLVANIA,PA,"$322,040"
Ovarian Cancer,2012,NCI,5R01CA138628-03,,Role of the BMP SMADs in Oncogenesis,"PANGAS, STEPHANIE",BAYLOR COLLEGE OF MEDICINE,TX,"$354,370"
Ovarian Cancer,2012,NCI,5R01CA133057-04,,Prognostic markers for ovarian cancer,"MOK, SAMUEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$309,964"
Ovarian Cancer,2012,NCI,5F32CA144898-02,,Role of Tumor Microenvironment in Ovarian Cancer Progression,"THOMPSON, MELISSA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$52,880"
Ovarian Cancer,2012,NCI,5R01CA099985-06,,Human Tregs in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$216,969"
Ovarian Cancer,2012,NCI,5R01CA132091-05,,Targeted Nanoparticle DNA Therapy for Ovarian Cancer,"SAWICKI, JANET",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$266,946"
Ovarian Cancer,2012,NCI,5R01CA148747-03,,Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer,"CLIBY, WILLIAM",MAYO CLINIC,MN,"$317,411"
Ovarian Cancer,2012,NCI,5R01CA101850-08,,ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING,"BAE, YOU",UNIVERSITY OF UTAH,UT,"$263,045"
Ovarian Cancer,2012,NCI,5R01CA129080-05,,The Roles of HBXAP Gene in Ovarian Cancer,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$330,091"
Ovarian Cancer,2012,NCI,5R01CA131200-04,,Regulation of Ovarian Cancer Multidrug Resistance by MAP Kinases,"EBLEN, SCOTT",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$296,116"
Ovarian Cancer,2012,NCI,5R01CA108970-08,,CD4+ Memory T-Cells in Human Tumor Microenvironment,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$296,719"
Ovarian Cancer,2012,NCI,5R01CA149429-03,,The Mitochondrial Genome and Ovarian Cancer Risk,"PHELAN, CATHERINE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$604,624"
Ovarian Cancer,2012,NICHD,5R01HD057110-05,,Molecular Pathways Controlling Ovarian Gene Expression,"STOCCO, CARLOS",UNIVERSITY OF ILLINOIS,IL,"$288,726"
Ovarian Cancer,2012,NCI,5R01CA123249-05,,Regulation of Serine Protease HtrA1 and Chemoresponse,"SHRIDHAR, VIJI",MAYO CLINIC,MN,"$304,127"
Ovarian Cancer,2012,NCI,5R01CA142832-03,,Novel Biomarkers in Ovarian Cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$347,562"
Ovarian Cancer,2012,NCI,5R01CA109298-08,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$322,654"
Ovarian Cancer,2012,NCI,5R01CA102707-08,,Inhibition  of Cytochrome c-induced Caspase Activation,"KORNBLUTH, SALLY",DUKE UNIVERSITY,NC,"$263,055"
Ovarian Cancer,2012,NCI,5R01CA095175-09,,Analysis of BRCA1 recombination functions,"SCULLY, RALPH",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$295,223"
Ovarian Cancer,2012,NCI,5R01CA108990-08,,Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$551,606"
Ovarian Cancer,2012,NIEHS,5R01ES005775-20,,"Hypoxia, Genetic Instability and DNA Mismatch Repair","GLAZER, PETER",YALE UNIVERSITY,CT,"$364,566"
Ovarian Cancer,2012,NCI,1R01CA163345-01,,Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics,"BUCKANOVICH, RONALD",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$313,450"
Ovarian Cancer,2012,NCI,7R01CA086984-13,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF NOTRE DAME,IN,"$295,464"
Ovarian Cancer,2012,NCI,1R01CA163462-01,,MUC1 Roles in ovarian cancer pathogenesis and immune therapy,"VLAD, ANDA",MAGEE-WOMEN'S RES INST AND FOUNDATION,PA,"$303,546"
Ovarian Cancer,2012,NCI,1R21CA165916-01,,Models for Consortium Level Analysis of GxE Interaction in Complex Disease,"IVERSEN, EDWIN",DUKE UNIVERSITY,NC,"$160,257"
Ovarian Cancer,2012,NCI,5R01CA133117-04,,Role of the Mullerian Tract in Ovarian Cancer Development,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$326,066"
Ovarian Cancer,2012,NCI,5R01CA157176-02,,"Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer","BICKELL, NINA",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$451,915"
Ovarian Cancer,2012,NCI,5R21CA156944-02,,Biophotonics Noninvasive Detection of Ovarian Cancer,"BACKMAN, VADIM",NORTHWESTERN UNIVERSITY,IL,"$316,438"
Ovarian Cancer,2012,NCI,2P30CA006516-47,6051,Gynecologic Cancers,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$93,382"
Ovarian Cancer,2012,NCI,5R03CA153815-02,,The High Cost of Risk Reduction: Addressing Sexual Dysfunction after Oophorectomy,"BOBER, SHARON",DANA-FARBER CANCER INSTITUTE,MA,"$87,500"
Ovarian Cancer,2012,NCI,5R01CA123219-05,,The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$307,535"
Ovarian Cancer,2012,NCI,1R21CA164593-01,,Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer,"ANDERSON, KAREN",ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,AZ,"$212,556"
Ovarian Cancer,2012,NCI,5R01CA123233-05,,Regulation of JNK-signaling molecules by the gep oncogenes,"DHANASEKARAN, DANNY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$241,288"
Ovarian Cancer,2012,NCI,5R01CA136549-04,,Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,"LU, XIONGBIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$318,015"
Ovarian Cancer,2012,NCI,1R15CA164622-01,,Antiprogestin therapy for ovarian cancer,"TELLERIA, CARLOS",UNIVERSITY OF SOUTH DAKOTA,SD,"$425,596"
Ovarian Cancer,2012,NCI,5R01CA155025-02,,The role of a novel BRCA1 associated complex in DNA damage response and tumor sup,"WANG, BIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,850"
Ovarian Cancer,2012,NCI,5R01CA138762-04,,Splicing factors as therapeutic targets for the treatment of ovarian cancer,"BECK, WILLIAM",UNIVERSITY OF ILLINOIS,IL,"$307,810"
Ovarian Cancer,2012,NCI,5R01CA148826-02,,Characterizing Notch3 Signaling in Ovarian Cancer,"WANG, TIAN-LI",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Ovarian Cancer,2012,NCI,1R01CA157481-01A1,,"Bmi-1, a potential therapeutic target in ovarian cancer","BHATTACHARYA, RESHAM",MAYO CLINIC,MN,"$344,461"
Ovarian Cancer,2012,NIGMS,5SC1GM082340-03,,The Fulvene Approach to the Syntheses of Antitumor Agents,"ERDEN, IHSAN",SAN FRANCISCO STATE UNIVERSITY,CA,"$265,939"
Ovarian Cancer,2012,NCI,5R01CA099471-08,,Gonadotropins & Cox-2 in Ovarian Cancer Prevention,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$375,915"
Ovarian Cancer,2012,NCI,5R01CA131965-04,,Defining a Pre-Malignant Phenotype in Fallopian Tube Epithelium,"SWISHER, ELIZABETH",UNIVERSITY OF WASHINGTON,WA,"$313,989"
Ovarian Cancer,2012,NCI,5R21CA137681-03,,A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers,"CHILES, THOMAS",BOSTON COLLEGE,MA,"$231,123"
Ovarian Cancer,2012,NCI,5R01CA085289-09,,DNA Methylation and Ovarian Cancer,"NEPHEW, KENNETH",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$233,953"
Ovarian Cancer,2012,NCI,5R03CA159080-02,,Mammographic Breast Density and Ovarian Cancer,"WERNLI, KAREN",GROUP HEALTH COOPERATIVE,WA,"$80,000"
Ovarian Cancer,2012,NCI,5R01CA136596-04,,"The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis","CONNOLLY, DENISE",FOX CHASE CANCER CENTER,PA,"$323,047"
Ovarian Cancer,2012,NCI,1R01CA158415-01A1,,Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$390,388"
Ovarian Cancer,2012,NIEHS,1R21ES020538-01A1,,"Novel triplex-engineered, BRCA1-mutated cell lines for research","GLAZER, PETER",YALE UNIVERSITY,CT,"$207,136"
Ovarian Cancer,2012,NCI,5R01CA141078-03,,Multifunctional roles of homeobox gene DLX4 in ovarian cancer,"NAORA, HONAMI",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$318,015"
Ovarian Cancer,2012,NCI,1K23CA159391-01A1,,Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus,"PEIKERT, TOBIAS",MAYO CLINIC,MN,"$164,160"
Ovarian Cancer,2012,NCI,5R01CA131183-05,,"RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression","LIU, JINSONG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$247,971"
Ovarian Cancer,2012,NCI,1R03CA165082-01,,Identification of regulatory cancer risk SNPs for chemoprevention discovery,"KLEIN, ROBERT",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$91,450"
Ovarian Cancer,2012,NCI,1R21CA159002-01A1,,Peptide-targeted alpha-particle emitting phage for ovarian cancer therapy.,"QUINN, THOMAS",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$203,732"
Ovarian Cancer,2012,NCI,5R01CA140323-03,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$362,225"
Ovarian Cancer,2012,NCI,5R01CA135006-04,,Role of TbRIII in Regulating Motility and Invasion,"BLOBE, GERARD",DUKE UNIVERSITY,NC,"$423,323"
Ovarian Cancer,2012,NCI,5R01CA158881-02,,Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$540,181"
Ovarian Cancer,2012,NCI,5R01CA136547-04,,Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer,"PENG, KAH-WHYE",MAYO CLINIC,MN,"$507,051"
Ovarian Cancer,2012,NCI,5R01CA134424-04,,A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc,"KOSTUK, RAYMOND",UNIVERSITY OF ARIZONA,AZ,"$398,474"
Ovarian Cancer,2012,NCI,5U10CA027469-32,,Gynecologic Oncology Group,"DISAIA, PHILIP",GYNECOLOGIC ONCOLOGY GROUP,MD,"$10,681,725"
Ovarian Cancer,2012,NCI,5R01CA115483-08,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$310,460"
Ovarian Cancer,2012,NCI,5R01CA138556-04,,Impact of exercise on ovarian cancer prognosis,"IRWIN, MELINDA",YALE UNIVERSITY,CT,"$606,353"
Ovarian Cancer,2012,NCI,5R01CA136494-04,,Molecular mechanism of antiangiogenic properties of gold nanoparticle,"MUKHERJEE, PRIYABRATA",MAYO CLINIC,MN,"$273,714"
Ovarian Cancer,2012,NCI,5R01CA149260-03,,Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy,"KUO, MACUS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$318,015"
Ovarian Cancer,2012,NCI,1F31CA165844-01,,Defining the role and regulation of the RhoGEF Ect2 in ovarian cancer cells,"HUFF, LAUREN",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$29,392"
Ovarian Cancer,2012,NCI,5R01CA142783-03,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA,VA,"$309,964"
Ovarian Cancer,2012,NCI,1R13CA165638-01,,Ovarian Cancer: Prevention of the Disease and Its Recurrence,"EDWARDS, ROBERT",MAGEE-WOMEN'S RES INST AND FOUNDATION,PA,"$10,000"
Ovarian Cancer,2012,NCI,5R01CA031841-32,,Synthetic Studies on Tumor Promoters and Inhibitors,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$327,560"
Ovarian Cancer,2012,NCI,5R01CA137041-04,,MicroRNAs in Human Ovarian Cancer,"CHENG, JIN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$336,129"
Ovarian Cancer,2012,NCI,5R01CA115780-07,,Diagnosis of Ovarian Cancer by Confocal Microendoscopy,"GMITRO, ARTHUR",UNIVERSITY OF ARIZONA,AZ,"$276,708"
Ovarian Cancer,2012,NCI,1R21CA165807-01,,Tumor Suppressor Role of ARID1A,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$176,175"
Ovarian Cancer,2012,NCI,5R01CA136491-04,,Development of an Assay for the Early Detection of Ovarian Cancer,"MOORE, RICHARD",WOMEN AND INFANTS HOSPITAL-RHODE ISLAND,RI,"$337,373"
Ovarian Cancer,2012,NCI,5R01CA127913-05,,MyD88-bearing tumors in immune-regulation and chemo-resistance,"MOR, GIL",YALE UNIVERSITY,CT,"$333,111"
Ovarian Cancer,2012,NCI,5R44CA144586-03,,IHC Test for BRCA1 Hereditary Ovarian Cancer,"HOLT, JEFFREY","TISSUE GENETICS, INC.",CO,"$399,246"
Ovarian Cancer,2012,NCI,5R01CA157664-02,,Initiation and evolution of the ovarian cancer microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$353,435"
Ovarian Cancer,2012,NCI,5K07CA143047-03,,Genetic Epidemiology of Ovarian and Prostate Cancer,"SIEH, WEIVA",STANFORD UNIVERSITY,CA,"$173,448"
Ovarian Cancer,2012,NCI,5K08CA148887-03,,Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer,"KHABELE, DINEO",VANDERBILT UNIVERSITY MED CTR,TN,"$159,084"
Ovarian Cancer,2012,NCI,5R03CA143918-02,,Characteristics of tubal ligation and risk of epithelial ovarian cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$96,177"
Ovarian Cancer,2012,NCI,5R01CA120659-05,,"Role of a novel angiogenic factor, YKL-40, in breast cancer progression","SHAO, RONG",UNIVERSITY OF MASSACHUSETTS AMHERST,MA,"$218,062"
Ovarian Cancer,2012,NCI,5R01CA142081-03,,Epidemiology of Ovarian Cancer in African-American Women,"SCHILDKRAUT, JOELLEN",DUKE UNIVERSITY,NC,"$2,226,299"
Ovarian Cancer,2012,NCI,5R01CA039742-28,,Epidemiology of Cancer in a Cohort of Older Women,"LAZOVICH, DEANN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$442,527"
Ovarian Cancer,2012,NCI,5R01CA136512-04,,BRCA1 Function in Post-Damage Nuclear Foci,"LIVINGSTON, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$511,599"
Ovarian Cancer,2012,NCI,5R01CA135179-04,,INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$421,283"
Ovarian Cancer,2012,NCI,5R01CA138533-03,,Multifunctional Nanotherapeutics for Cancer Treatment and Imaging,"MINKO, TAMARA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$310,035"
Ovarian Cancer,2012,NCI,5R01CA130911-05,,Chimeric NKG2D receptors in ovarian cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$321,839"
Ovarian Cancer,2012,NCI,5R01CA135312-05,,Dendritic nanomedicine for cancer imaging and treatment,"TUNG, CHING-HSUAN",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$301,913"
Ovarian Cancer,2012,NCI,5R01CA149356-12,,The Role of MicroRNAs in Tumor Progression,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$272,177"
Ovarian Cancer,2012,NCI,5R01CA140933-04,,Biobehavioral Influences and the Ovarian Tumor Microenvironment,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$524,647"
Ovarian Cancer,2012,NCI,5R01CA126841-04,,Regulatory T Cell Function in Ovarian Cancer,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$587,055"
Ovarian Cancer,2012,NCI,5R01CA129142-04,,Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women,"KINNEY, ANITA",UNIVERSITY OF UTAH,UT,"$550,522"
Ovarian Cancer,2012,NIBIB,5R01EB011523-03,,Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu,"CHOI, HAK SOO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$489,414"
Ovarian Cancer,2012,NCI,5R01CA058598-14,,Collaborative Genetic Study of Ovarian Cancer Risk,"GOODMAN, MARC",UNIVERSITY OF HAWAII AT MANOA,HI,"$471,383"
Ovarian Cancer,2012,NCI,5R01CA131400-04,,VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER,"SPRINGETT, GREGORY",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$336,129"
Ovarian Cancer,2012,NHLBI,1R21HL113439-01,,Regulation of Macrophage Reverse Cholesterol Transport by BRCA1,"SCHULMAN, IRA",UNIVERSITY OF VIRGINIA,VA,"$192,500"
Ovarian Cancer,2012,NINR,5R01NR010735-05,,Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-Directed,"DONOVAN, HEIDI",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$553,640"
Ovarian Cancer,2012,NCI,5R37CA070867-15,,Cancer Risk Reduction and Diet: A Cohort Study of Women,"ZHENG, WEI",VANDERBILT UNIVERSITY MED CTR,TN,"$948,106"
Ovarian Cancer,2012,NCI,5R01CA135354-04,,ARHI (DIRAS 3) in Autophagy and Dormancy of Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$306,953"
Ovarian Cancer,2012,NCI,5R01CA132755-05,,MOLECULAR MECHANISMS OF BRCA1-DEPENDENT DNA DAMAGE RESPONSE AND TUMORIGENESIS,"YU, XIAOCHUN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$305,938"
Ovarian Cancer,2012,NCI,5R01CA060731-18,,AFAP-110 as a cSrc activator in breast cancer,"FLYNN, DANIEL",COMMONWEALTH MEDICAL COLLEGE,PA,"$227,829"
Ovarian Cancer,2012,NIGMS,5R01GM032136-30,,Molecular Recognition of Proteins and Ligand Design,"JORGENSEN, WILLIAM",YALE UNIVERSITY,CT,"$369,110"
Ovarian Cancer,2012,NCI,5R01CA122443-06,,Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology,"GOODE, ELLEN",MAYO CLINIC,MN,"$18,847"
Ovarian Cancer,2012,NCI,5R01CA151570-02,,Co-registered photoacoustic and ultrasound  imaging  for non-invasive ovarian can,"ZHU, QUING",UNIVERSITY OF CONNECTICUT STORRS,CT,"$323,537"
Ovarian Cancer,2012,NCI,5R01CA154460-02,,CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$344,277"
Ovarian Cancer,2012,NCI,5K08CA151892-02,,Targeting Src Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer,"SIMPKINS, FIONA",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$161,488"
Ovarian Cancer,2012,NCI,5R21CA156224-02,,Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$348,000"
Ovarian Cancer,2012,NCI,1R01CA158119-01A1,,Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$566,874"
Ovarian Cancer,2012,NCI,5R01CA131582-04,,Identification of ovarian cancer plasma biomarkers,"SPEICHER, DAVID",WISTAR INSTITUTE,PA,"$428,620"
Ovarian Cancer,2012,NCI,1R01CA160669-01A1,,Mitochondrial DNA and Ovarian Cancer Risk and Survival,"COOK, LINDA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$542,855"
Ovarian Cancer,2012,NCI,5R03CA157212-02,,Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers,"BUCHANAN, ADAM",DUKE UNIVERSITY,NC,"$84,884"
Ovarian Cancer,2012,NCI,2R01CA111882-06,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$272,318"
Ovarian Cancer,2012,NCI,5R01CA085566-08,,Psychological Intervention for Ovarian Cancer Patients,"MANNE, SHARON",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$519,072"
Ovarian Cancer,2012,NCI,5R01CA125231-06,,A Multi-State Study of Cancer Treatment and Outcomes Among American Indians,"RAMSEY, SCOTT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$374,097"
Ovarian Cancer,2012,NCI,5R00CA133190-05,,Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer,"COWDEN DAHL, KAREN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$241,530"
Ovarian Cancer,2012,NCI,2P30CA046592-24,6455,Cancer Genetics,"WICHA, MAX",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$301,699"
Ovarian Cancer,2012,NCCAM,5R01AT005295-02,,Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer,"HALES, DALE",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$360,113"
Ovarian Cancer,2012,NCI,5R21CA155479-02,,Use of nanogels to target delivery of siRNA to cancer cells in mice,"MCDONALD, JOHN",GEORGIA INSTITUTE OF TECHNOLOGY,GA,"$247,687"
Ovarian Cancer,2012,NIBIB,1R21EB014572-01A1,,Intracellular delivery of proapoptotic peptide drugs for the treatment of cancer,"STAYTON, PATRICK",UNIVERSITY OF WASHINGTON,WA,"$256,194"
Ovarian Cancer,2012,NCI,1R03CA162140-01A1,,Parental age at birth and risk of adult-onset cancer in female offspring,"LU, YANI",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$84,000"
Ovarian Cancer,2012,NCI,5R01CA141154-03,,Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data,"PEARCE, CELESTE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$605,846"
Ovarian Cancer,2012,NCI,5R01CA151374-03,,Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients,"MARTIN, LAINIE",FOX CHASE CANCER CENTER,PA,"$426,421"
Ovarian Cancer,2012,NIBIB,2R01EB007268-05,,Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity,"YANG, JENNY",GEORGIA STATE UNIVERSITY,GA,"$446,352"
Ovarian Cancer,2012,NCI,1R03CA167765-01,,Effect of exercise on cortisol dysregulation in ovarian cancer survivors,"CARTMEL, BRENDA",YALE UNIVERSITY,CT,"$82,938"
Ovarian Cancer,2012,NCI,5K05CA136967-04,,Research and Mentoring on Energetic Factors and Cancer: Established Investigator,"BERNSTEIN, LESLIE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$137,885"
Ovarian Cancer,2012,NCI,5R01CA112240-07,,The role of Fas as tumor promoter,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$294,148"
Ovarian Cancer,2012,NCI,5R01CA160998-02,,Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$399,919"
Ovarian Cancer,2012,NCI,5R01CA127239-05,,pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics,"NATARAJAN, AMARNATH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$270,598"
Ovarian Cancer,2012,NCI,5U01CA152755-03,,An integrated systems biology approach for ovarian cancer biomarker discovery,"DIAMANDIS, ELEFTHERIOS",MT SINAI HOSP-SAMUEL LUNENFELD RES INST,CANADA,"$190,288"
Ovarian Cancer,2012,NCI,5U01CA152990-03,,"Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery","SKATES, STEVEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$701,365"
Ovarian Cancer,2012,NCI,5R21CA160917-02,,Role of the Fractalkine Signaling in EOC,"BARBOLINA, MARIA",UNIVERSITY OF ILLINOIS,IL,"$168,249"
Ovarian Cancer,2012,NCI,5K07CA131094-05,,Epigentics and Female Reproductive Cancers,"PERRIN, MARY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$139,320"
Ovarian Cancer,2012,NCI,5U01CA084955-13,,Atlantic Breast and Gynecologic Clinical Validation Center,"MARKS, JEFFREY",DUKE UNIVERSITY,NC,"$479,070"
Ovarian Cancer,2012,NIDCR,5R03DE021438-02,,Genetic Markers Associated with Epithelial Ovarian Cancer and Hypodontia,"MORFORD, LORRI",UNIVERSITY OF KENTUCKY,KY,"$111,375"
Ovarian Cancer,2012,NIAID,5SC1AI089073-04,,Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,"SON, DEOK-SOO",MEHARRY MEDICAL COLLEGE,TN,"$358,962"
Ovarian Cancer,2012,NCI,5R21CA155424-02,,Enzyme-delivery scaffold technology for targeted cancer killing.,"LAVIE, ARNON",UNIVERSITY OF ILLINOIS,IL,"$231,674"
Ovarian Cancer,2012,NCI,5K22CA138563-03,,Obesity in ovarian cancer prognosis,"BANDERA, ELISA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$201,381"
Ovarian Cancer,2012,NCI,1F30CA167895-01,,Molecular analysis of the function of BRCA1-TONSL complexes,"HILL, SARAH",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$44,874"
Ovarian Cancer,2012,NCI,5R44CA140047-04,,Cancer Progeniyor Cell Markers,"CHEN, WEN-TIEN","VITATEX, INC.",NY,"$703,024"
Ovarian Cancer,2012,NCI,1F31CA168180-01,,A novel model system for risk assessment of BRCA carriers,"COCHRAN, RORY",JOHNS HOPKINS UNIVERSITY,MD,"$42,232"
Ovarian Cancer,2012,NCI,1F32CA168309-01,,A Role for Fatty Acid Binding Protein 4 in Ovarian Cancer Metastasis,"NIEMAN, KRISTIN",UNIVERSITY OF CHICAGO,IL,"$53,942"
Ovarian Cancer,2012,NCI,5R03CA162511-02,,Fish oil for the prevention and treatment of ovarian cancer,"HALES, DALE",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$72,750"
Ovarian Cancer,2012,NCI,5R01CA075334-15,,MRI studies of angiogenesis in ovarian cancer,"NEEMAN, MICHAL",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$102,771"
Ovarian Cancer,2012,NCI,5R01CA160541-02,,Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer,"TAINSKY, MICHAEL",WAYNE STATE UNIVERSITY,MI,"$315,400"
Ovarian Cancer,2012,NIGMS,8R21GM103536-02,,Development of Nanoproteomic Technologies,"LEE, CHENG",UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS,MD,"$187,500"
Ovarian Cancer,2012,NIGMS,5R01GM097495-02,,"Cross-talk between PKA, cellular tension, and Ca2+ channels during cell migration","HOWE, ALAN",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$332,114"
Ovarian Cancer,2012,NCI,1U01CA168409-01,,COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS,"POWERS, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$1,405,573"
Ovarian Cancer,2012,NCI,5U24CA160036-02,,Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers,"CHAN, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$1,875,068"
Ovarian Cancer,2012,NCI,5R01CA158318-02,,mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$334,591"
Ovarian Cancer,2012,NCI,5R33CA147988-02,,Development and Application of Novel Glycan-Specific Reagents to Facilitate Early,"MUDDIMAN, DAVID",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$353,783"
Ovarian Cancer,2012,NCI,5U01CA152637-03,,Breast and Ovary Cancer Clinical Validation Center,"LI, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$973,064"
Ovarian Cancer,2012,NCI,5R43CA159478-02,,Utrasensitive bioassays using palladium catalyzed chemical amplification,"LELENTAL, MARK","BIOFORMATIX, INC.",CA,"$100,578"
Ovarian Cancer,2012,NCI,5U01CA151648-04,,RNA Nanotechnology in Cancer Therapy,"GUO, PEIXUAN",UNIVERSITY OF KENTUCKY,KY,"$408,591"
Ovarian Cancer,2012,NHGRI,5R21HG006415-02,,Genetic Education to Promote Counseling Attendance after Surgical Treatment (GET,"VADAPARAMPIL, SUSAN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$208,750"
Ovarian Cancer,2012,NCI,5U01CA151461-03,,Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer,"O'HALLORAN, THOMAS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$396,261"
Ovarian Cancer,2012,NCI,5R03CA162103-02,,Bilateral oophorectomy and cancer risk and mortality in African American women,"BOGGS, DEBORAH",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$61,751"
Ovarian Cancer,2012,NCI,5R33CA155618-02,,Array Microscope Assay for Cancer Cell Mechanics,"SUPERFINE, RICHARD",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$309,109"
Ovarian Cancer,2012,NCI,5R21CA161478-02,,Regulation of lipogenesis by lysophosphatidic acid in ovarian cancer,"FANG, XIANJUN",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$195,098"
Ovarian Cancer,2012,NCI,1U01CA168870-01,,Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer,"ABBOTT, KAREN",UNIVERSITY OF GEORGIA (UGA),GA,"$355,985"
Ovarian Cancer,2012,NCI,1K99CA168987-01,,Discovering genomic rearrangements under selection in serious ovarian cancer,"SALZMAN, JULIA",STANFORD UNIVERSITY,CA,"$110,132"
Ovarian Cancer,2012,NCI,1R01CA163377-01A1,,Role of EZH2 in Epithelial Ovarian Cancer,"ZHANG, RUGANG",WISTAR INSTITUTE,PA,"$316,168"
Ovarian Cancer,2012,NCI,1R01CA163451-01A1,,"Psychological stress, associate biologic mediators, and ovarian cancer risk","TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$469,872"
Ovarian Cancer,2012,NCI,1R01CA163018-01A1,,Prospective Study of Serum MIS and Gynecologic Cancer Risk,"DORGAN, JOANNE",INSTITUTE FOR CANCER RESEARCH,PA,"$578,744"
Ovarian Cancer,2012,NCI,1R01CA164729-01A1,,"Integrative Cancer Genomics: Drivers, Pathways and Drugs","PE'ER, DANA",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$399,632"
Ovarian Cancer,2012,NCI,1R01CA164122-01A1,,B7-H1 Signaling in Ovarian Cancer,"CURIEL, TYLER","UNIV OF TX HSC, SA",TX,"$310,040"
Ovarian Cancer,2012,NCI,2R01CA068682-21A1,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN",UNIVERSITY OF TEXAS AUSTIN,TX,"$319,550"
Ovarian Cancer,2012,NCI,1K08CA163603-01A1,,Antibody directed delivery of short interfering RNA for the treatment of ovarian,"PALANCA-WESSELS, MARIA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$170,631"
Ovarian Cancer,2012,NCI,1R21CA170195-01,,An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9),"DUPUY, ADAM",UNIVERSITY OF IOWA,IA,"$164,213"
Ovarian Cancer,2012,NCI,5P01CA070970-14,0006,Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$312,066"
Ovarian Cancer,2012,NCI,5P30CA077598-14,5757,Women's Cancer,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$36,859"
Ovarian Cancer,2012,NCI,5P01CA087969-13,7547,Ovarian Cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$166,923"
Ovarian Cancer,2012,NCI,5P01CA087969-13,7548,Statistical Methods,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$114,846"
Ovarian Cancer,2012,NCI,5P01CA087969-13,7551,Biologic Specimen Management Core,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$473,805"
Ovarian Cancer,2012,NCI,5U19CA148112-03,8865,Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI),"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$235,559"
Ovarian Cancer,2012,NCI,5U19CA148112-03,8866,"Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)","SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$704,637"
Ovarian Cancer,2012,NCI,5U19CA148112-03,8867,Functional assessment of genes and common genetic risk variants in ovarian cancer,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$767,203"
Ovarian Cancer,2012,NCI,5U19CA148112-03,8868,Genetic and environmental interaction analyses and risk prediction modeling,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$707,617"
Ovarian Cancer,2012,NCI,5P30CA118100-08,6320,Womens Cancers Research Program,"PROSSNITZ, ERIC",UNIVERSITY OF NEW MEXICO,NM,"$40,968"
Ovarian Cancer,2012,NCI,5U54CA151459-03,8855,Next Generation Smart Nanoparticles,"ALIVISATOS, PAUL",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$981,050"
Ovarian Cancer,2012,NCI,5U54CA151459-03,8856,Magneto-Nano Diagnostic and Analytical Devices for Cancer,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$262,335"
Ovarian Cancer,2012,NCI,5U54CA151459-03,8858,Integration of Nano-Molecular Imaging and Nanosensors,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$177,117"
Ovarian Cancer,2012,NCI,5U54CA151459-03,8865,Pilot Projects,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$58,394"
Ovarian Cancer,2012,NCI,5U54CA151662-03,8769,Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer,"GERNGROSS, TILLMAN",DARTMOUTH COLLEGE,NH,"$295,924"
Ovarian Cancer,2012,NCI,5U54CA151662-03,8772,Magnetic nanoparticle Immunotherapy against Ovarian Cancer,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$318,011"
Ovarian Cancer,2012,NCI,5U54CA151662-03,8775,"Toxicology, Pathology and Biodistribution Core (TPB Core)","LEWIS, LIONEL",DARTMOUTH COLLEGE,NH,"$174,166"
Ovarian Cancer,2012,NCI,5P30CA014236-38,6412,Breast and Ovarian Oncology,"BERCHUCK, ANDREW",DUKE UNIVERSITY,NC,"$26,728"
Ovarian Cancer,2012,NCI,5P30CA006927-49,8440,Histopathology,"SEIDEN, MICHAEL",FOX CHASE CANCER CENTER,PA,"$57,099"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7964,Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$147,388"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7965,Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V,"DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$272,565"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7966,MicroRNA Signature of Poorly Resectable Ovarian Cancer,"TEWARI, MUNEESH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$210,642"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7967,Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$280,192"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7968,Vaccinating against IGFBP-2 to prevent ovarian cancer relapse,"DISIS, MARY",UNIVERSITY OF WASHINGTON,WA,"$346,643"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7969,Leadership and Administration Core,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$164,031"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7970,Clinical Specimen Management and Characterization Core,"KNUDSEN, BEATRICE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$308,270"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7971,"Participant Recruitment, Enrollment and Characterization Core","DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$247,763"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7972,Biostatistics and Informatics Core,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$185,706"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7973,Developmental Research Program,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$66,479"
Ovarian Cancer,2012,NCI,5P50CA083636-14,7974,Career and Mentoring Development Program,"COLLINS, STEVEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$66,479"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7762,P1 - Early Detection of Epithelial Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$864,877"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7764,P2 - Targeting DII4-Notch Signaling in Ovarian Cancer,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$207,175"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7767,P3 - Personalized Therapy for Low-Grade Serous Carcinoma of the Ovary,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$208,290"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7768,P4 - Pers. Therapy for High-Grade Ovarian Cancer: Targeting PI3Kness & BRCAne,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$184,534"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7770,P5 - Gene-modified MSCs for Controlling Ovarian Cancer,"MARINI, FRANK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$186,856"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7771,Administrative Core,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$26,159"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7772,"Biostatistics, Bioinformatics and Systems Biology (BBSB) Core","ATKINSON, E",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$287,346"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7773,Pathology Core,"BROADDUS, RUSSELL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$121,897"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7774,Developmental Research Program,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$84,085"
Ovarian Cancer,2012,NCI,5P50CA083639-13,7775,Career Developmental Program,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$56,057"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7923,Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer,"KAUFMANN, SCOTT",MAYO CLINIC,MN,"$350,594"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7924,Mechanisms of Immune Suppression in Ovarian Cancer,"KNUTSON, KEITH",MAYO CLINIC,MN,"$327,530"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7925,Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer,"GALANIS, EVANTHIA",MAYO CLINIC,MN,"$372,958"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7926,Flavopiridol Reverses Platinum Resistance in Ovarian Cancer,"BIBLE, KEITH",MAYO CLINIC,MN,"$238,831"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7927,Administration Core,"HARTMANN, LYNN",MAYO CLINIC,MN,"$234,806"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7928,Biospecimens/Patient Registry Core,"BELL, DEBRA",MAYO CLINIC,MN,"$197,531"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7929,Biostatistics Core,"OBERG, ANN",MAYO CLINIC,MN,"$204,874"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7930,Animal Models,"KNUTSON, KEITH",MAYO CLINIC,MN,"$171,472"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7931,Developmental Research Program,"KAUFMANN, SCOTT",MAYO CLINIC,MN,"$134,270"
Ovarian Cancer,2012,NCI,5P50CA136393-04,7932,Career Development Program,"COUCH, FERGUS",MAYO CLINIC,MN,"$67,134"
Ovarian Cancer,2012,NCI,5U54CA151819-03,8878,"Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an","HOOD, LEROY",INSTITUTE FOR SYSTEMS BIOLOGY,WA,"$703,861"
Ovarian Cancer,2012,NCI,5U54CA151819-03,8879,Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy,"RADU, CAIUS",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$367,673"
Ovarian Cancer,2012,NCI,5U54CA151819-03,8883,Administrative Core,"HEATH, JAMES",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$111,996"
Ovarian Cancer,2012,NCI,5P50CA083638-14,7949,Gene Methylation Signatures for Predictive Classification of Response to Therapy,"CAIRNS, PAUL",FOX CHASE CANCER CENTER,PA,"$785,372"
Ovarian Cancer,2012,NCI,5P50CA083638-14,7950,Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C,"DALY, MARY",FOX CHASE CANCER CENTER,PA,"$343,633"
Ovarian Cancer,2012,NCI,5P50CA083638-14,7951,Therapeutic Micro RNA Strategies for Ovarian Cancer,"HAMILTON, THOMAS",FOX CHASE CANCER CENTER,PA,"$426,838"
Ovarian Cancer,2012,NCI,5P50CA083638-14,7952,Targeting Signaling Networks Via Novel RNAi Approaches to Improve Therapy for O,"GODWIN, ANDREW",FOX CHASE CANCER CENTER,PA,"$242,445"
Ovarian Cancer,2012,NCI,5P50CA083638-14,7955,Advancing T cell Therapy for Ovarian Cancer,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$450,053"
Ovarian Cancer,2012,NCI,5P50CA083638-14,7956,Administrative Core,"SEIDEN, MICHAEL",FOX CHASE CANCER CENTER,PA,"$51,659"
Ovarian Cancer,2012,NCI,5U54CA151881-03,5122,Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA,"TORCHILIN, VLADIMIR",NORTHEASTERN UNIVERSITY,MA,"$754,495"
Ovarian Cancer,2012,NCI,5U54CA151881-03,5124,Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance,"MINKO, TAMARA",RUTGERS THE STATE UNIVERSITY OF NJ,NJ,"$266,219"
Ovarian Cancer,2012,NCI,5U54CA151668-03,8844,Multistage Vectors (MSV) for Ovarian Cancer Therapeutics,"LOPEZ-BERESTEIN, GABRIEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$394,913"
Ovarian Cancer,2012,NCI,5U54CA151668-03,8845,Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$366,609"
Ovarian Cancer,2012,NCI,5U54CA151668-03,8847,Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri,"ARAP, WADIH",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$318,072"
Ovarian Cancer,2012,NCI,5U54CA151884-03,5023,Nanoformulations for siRNA Delivery to Ovarian Cancer,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$255,250"
Ovarian Cancer,2012,NCI,5F31CA145736-02,,Smart Packaging: A Novel Technique for Localized Drug Delivery for Ovarian Cancer,"WILLIAMS, EVA CHRISTABEL",UNIVERSITY OF SOUTH FLORIDA,FL,"$32,609"
Ovarian Cancer,2012,NCI,1R21CA164839-01A1,,Linking tumor chemoresistance to TLR variants that mediate damage chain reaction,"SCHOLLER, NATHALIE",UNIVERSITY OF PENNSYLVANIA,PA,"$208,800"
Ovarian Cancer,2012,NCI,7R01CA109545-06,,Receptor Cross-Talk in Early Metastatic Dissemination,"STACK, MARY",UNIVERSITY OF NOTRE DAME,IN,"$298,049"
Ovarian Cancer,2012,NHLBI,2R44HL099217-02A1,,ChNKG2D-Targeted Cellular Cancer Therapy: Phase I Clinical Trial,"FANGER, MICHAEL","CELDARA MEDICAL, LLC",NH,"$1,399,888"
Ovarian Cancer,2012,NCI,2R44CA139841-02A1,,A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC,"PRABHAKARPANDIAN, BALABHASKAR",CFD RESEARCH CORPORATION,AL,"$633,309"
Ovarian Cancer,2012,NCI,1R41CA168228-01A1,,Integrin Targeted Therapy for the Treatment of Ovarian Cancer,"MARKLAND, FRANCIS","APPLIED INTEGRIN SCIENCES, INC.",CA,"$299,849"
Ovarian Cancer,2012,NCI,3R01CA133117-04S1,,Role of the Mullerian Tract in Ovarian Cancer Development,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$58,236"
Ovarian Cancer,2012,NCI,1F31CA165528-01A1,,The Functional Analysis of Ovarian Cancer Susceptibility Locus 9p22.2,"PRICE, MELISSA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$42,232"
Ovarian Cancer,2012,NCI,1F30CA171715-01,,Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer,"LOU, DIANNE",UNIVERSITY OF TEXAS AUSTIN,TX,"$32,232"
Ovarian Cancer,2012,NCI,3U10CA027469-31S2,,Gynecologic Oncology Group,"DISAIA, PHILIP",GYNECOLOGIC ONCOLOGY GROUP,MD,"$109,000"
Ovarian Cancer,2012,NCI,1R03CA171617-01,,Ovarian Cancer Initiating Cells: Metabolic Characterization,"MURPHY, SUSAN",DUKE UNIVERSITY,NC,"$78,500"
Ovarian Cancer,2012,RMAP,1R03MH097485-01A1,,Discovering modulators of PAX8 for targeting ovarian cancer,"HAHN, WILLIAM",DANA-FARBER CANCER INSTITUTE,MA,"$43,750"
Ovarian Cancer,2012,RMAP,1R03MH097507-01A1,,Molecular probes for a vOTU from CCHFV using a fluorogenic peptide,"PEGAN, SCOTT",UNIVERSITY OF DENVER (COLORADO SEMINARY),CO,"$36,850"
Ovarian Cancer,2012,NCI,5F31CA159804-02,,Integrin Linked Kinase and Ovarian Cancer Metastasis,"BRUNEY, LANA",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$28,690"
Ovarian Cancer,2012,NIGMS,3P41GM103533-17S1,,Comprhensive Biology:  Exploiting the Yeast Genome,"DAVIS, TRISHA",UNIVERSITY OF WASHINGTON,WA,"$354,061"
Ovarian Cancer,2012,NCI,1K01CA172591-01,,"EGF receptor, DNA methylation and platinum resistance in ovarian cancer","SAMUDIO-RUIZ, SABRINA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$114,405"
Ovarian Cancer,2012,NCI,261200800001E-51-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$2,574,308"
Ovarian Cancer,2012,NCI,2R01CA124515-07A1,,Vascular Leukocytes Influence the Tumor Microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$318,839"
Ovarian Cancer,2012,NCI,1K22CA166226-01A1,,Targeting c-MYC Overcomes Temsirolimus and Cisplatin Resistance of Ovarian Cancer,"VIVAS-MEJIA, PABLO",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$181,369"
Ovarian Cancer,2012,NIGMS,3R01GM077309-04S1,,Methods for Bioactive Compound Synthesis,"HANSON, PAUL",UNIVERSITY OF KANSAS LAWRENCE,KS,"$87,268"
Ovarian Cancer,2012,NIA,1F31AG040937-01A1,,Cognitive Functioning Following Ovarian Removal Before or After Natural Menopause,"KURITA, KEIKO",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$39,852"
Ovarian Cancer,2012,NCI,7U54CA113001-08,8572,Interrogating Epigenetic Changes in Cancer Genomes,"HUANG, TIM",OHIO STATE UNIVERSITY,OH,"$1,536,572"
Ovarian Cancer,2012,NCI,1R43CA165848-01A1,,Targeting the ERCC1/XPF nuclease for cancer therapy,"FELTGEN, ROBERT","NERX BIOSCIENCES, INC.",IN,"$299,922"
Ovarian Cancer,2012,NCI,1R43CA168014-01A1,,Characterization of antitumor auto-antibodies using combinatorial peptide librari,"MANDECKI, WLODEK","PHARMASEQ, INC.",NJ,"$272,360"
Ovarian Cancer,2012,NCI,1F31CA174316-01,,Structural mutation analysis of PTEN and its possible genotype-phenotype correlat,"SMITH, IRIS",UNIVERSITY OF HOUSTON,TX,"$27,734"
Ovarian Cancer,2012,NCI,1R01CA164940-01A1,,A Novel Approach for the Routine Screening for Ovarian Cancer,"PANNELL, LEWIS",UNIVERSITY OF SOUTH ALABAMA,AL,"$321,198"
Ovarian Cancer,2012,NCI,3RC2CA148268-02S1,,"Functional Annotation of Cancer Genomes: TCGA, Glioblastoma and Ovarian Cancer","HAHN, WILLIAM",DANA-FARBER CANCER INSTITUTE,MA,"$639,047"
Ovarian Cancer,2012,NCI,1U54CA163071-01A1,7991,Identifying Cancer Health Communication Channels for Hispanic Audiences,"JIMENEZ, JUILO",PONCE SCHOOL OF MEDICINE,PR,"$90,081"
Ovarian Cancer,2012,NCI,1U54CA163068-01A1,8073,Identifying Cancer Health Communication Channels for Hispanic Audiences,"QUINN, GWENDOLYN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$50,549"
Ovarian Cancer,2012,NCI,N02CN63300-11-0-4,,Computer Support for Ovarian Cancer Screening in PLCO Cancer Screening Trials,"LAKE, WILLIAM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$446,688"
Ovarian Cancer,2012,NCI,5F32CA159558-02,,Role of p190RhoGEF (Rgnef) in cell motility and tumor progression,"MILLER, NICHOL",UNIVERSITY OF CALIFORNIA AT SAN DIEGO,CA,"$55,670"
Ovarian Cancer,2012,NCI,3R33CA147988-02S1,,Development and Application of Novel Glycan-Specific Reagents to Facilitate Early,"MUDDIMAN, DAVID",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$55,436"
Ovarian Cancer,2012,NCI,3R01CA079716-13S1,,Ovarian Cancer: Epithelial Dedifferentiation,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$30,548"
Ovarian Cancer,2012,NCI,3R01CA132755-05S1,,MOLECULAR MECHANISMS OF BRCA1-DEPENDENT DNA DAMAGE RESPONSE AND TUMORIGENESIS,"YU, XIAOCHUN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$31,251"
Ovarian Cancer,2012,OD,3R01CA132755-05S1,,MOLECULAR MECHANISMS OF BRCA1-DEPENDENT DNA DAMAGE RESPONSE AND TUMORIGENESIS,"YU, XIAOCHUN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$18,750"
Ovarian Cancer,2012,NIGMS,3R01GM097495-01S1,,"Cross-talk between PKA, cellular tension, and Ca2+ channels during cell migration","HOWE, ALAN",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$3,851"
Ovarian Cancer,2012,NCI,5F32CA159523-02,,Understanding the origin and pathogenesis of epithelial ovarian cancer,"KIM, JAEYEON",BAYLOR COLLEGE OF MEDICINE,TX,"$55,670"
Ovarian Cancer,2012,NICHD,4R00HD059985-03,,GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer,"WANG, CHENG",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$251,060"
Ovarian Cancer,2012,NCI,3R01CA115483-08S1,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$38,683"
Ovarian Cancer,2012,NCI,3R01CA142783-03S1,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA,VA,"$47,656"
Ovarian Cancer,2012,NIAID,4K06AI004739-51,,BIOCHEMISTRY OF VIRAL REPLICATION,"GREEN, MAURICE",SAINT LOUIS UNIVERSITY,MO,"$33,939"
Ovarian Cancer,2012,NCI,3P30CA077598-14S1,5757,Women's Cancer,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$2,678"
Ovarian Cancer,2012,NCI,3R01CA140933-04S1,,Biobehavioral Influences and the Ovarian Tumor Microenvironment,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$43,680"
Ovarian Cancer,2012,NCI,3P30CA014236-38S1,6412,Breast and Ovarian Oncology,"BERCHUCK, ANDREW",DUKE UNIVERSITY,NC,"$2,500"
Ovarian Cancer,2012,NCI,3P30CA077598-14S2,5757,Women's Cancer,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,776"
Ovarian Cancer,2012,NCI,261200900010C-6-0-3,,Informatics Support Center for the Cancer Family Registries,"MADHAVEN, SUBHA",GEORGETOWN UNIVERSITY,DC,"$1,200,000"
Ovarian Cancer,2012,NCI,3R01CA115483-08S2,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$77,226"
Ovarian Cancer,2012,NCI,3P30CA118100-08S1,6320,Womens Cancers Research Program,"PROSSNITZ, ERIC",UNIVERSITY OF NEW MEXICO,NM,"$7,778"
Ovarian Cancer,2012,NCI,3P30CA118100-08S2,6320,Womens Cancers Research Program,"PROSSNITZ, ERIC",UNIVERSITY OF NEW MEXICO,NM,"$4,166"
Ovarian Cancer,2012,NCI,1U54CA163068-01A1,8821,Identifying Cancer Health Communication Channels for Hispanic Audiences,"QUINN, GWENDOLYN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$50,549"
Ovarian Cancer,2012,NIA,1ZIAAG000395-05,,Expression and roles of claudin-3 and claudin-4 in ovarian cancer,"MORIN, PATRICE",NIH,,"$822,709"
Ovarian Cancer,2012,NIA,1ZIAAG000396-05,,Mechanisms of drug resistance in ovarian cancer,"MORIN, PATRICE",NIH,,"$226,954"
Ovarian Cancer,2012,NIA,1ZIAAG000397-05,,Claudin-7 in ovarian cancer,"MORIN, PATRICE",NIH,,"$283,693"
Ovarian Cancer,2012,NIA,1ZIAAG000398-05,,Expression and roles of microRNAs in ovarian tumorigenesis,"MORIN, PATRICE",NIH,,"$539,016"
Ovarian Cancer,2012,NCI,1ZIABC006161-29,,DNA Topoisomerases as Target of Action of Anticancer Drugs,"POMMIER, YVES",NIH,,"$1,217,866"
Ovarian Cancer,2012,NCI,1ZIABC009052-23,,Papillomavirus Virion Proteins and Vaccines,"SCHILLER, JOHN",NIH,,"$2,104,241"
Ovarian Cancer,2012,NCI,1ZIABC010027-18,,Function of Steroid Receptors in Subcellular Compartments,"HAGER, GORDON",NIH,,"$332,833"
Ovarian Cancer,2012,NCI,1ZIABC010030-17,,Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,"AMBUDKAR, SURESH",NIH,,"$1,144,762"
Ovarian Cancer,2012,NCI,1ZIABC010549-10,,Zebrafish Models of Cancer,"HICKSTEIN, DENNIS",NIH,,"$811,990"
Ovarian Cancer,2012,NCI,1ZIABC010657-08,,Intracellular In vivo Imaging,"CHOYKE, PETER",NIH,,"$1,402,125"
Ovarian Cancer,2012,NCI,1ZIABC010757-07,,Clinical trial development in cancer vaccines,"KHLEIF, SAMIR",NIH,,"$199,105"
Ovarian Cancer,2012,NCI,1ZIABC010830-06,,Mechanisms of non-classical multidrug resistance in cancer,"GOTTESMAN, MICHAEL",NIH,,"$908,705"
Ovarian Cancer,2012,NCI,1ZIABC010891-05,,Antibody Therapy of Cancer,"HO, MITCHELL",NIH,,"$735,484"
Ovarian Cancer,2012,NCI,1ZIABC010935-05,,Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,"STRACKE, MARY",NIH,,"$260,190"
Ovarian Cancer,2012,NCI,1ZIABC010970-05,,The connection of innate and adaptive anti-cancer immunity,"GREINER, JOHN",NIH,,"$937,885"
Ovarian Cancer,2012,NCI,1ZIABC011054-05,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$821,257"
Ovarian Cancer,2012,NCI,1ZIABC011055-05,,Serum Antibody Profiling with a Carbohydrate Microarray,"GILDERSLEEVE, JEFF",NIH,,"$551,526"
Ovarian Cancer,2012,NCI,1ZIABC011188-04,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$909,984"
Ovarian Cancer,2012,NCI,1ZIABC011197-04,,Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,"APPELLA, ETTORE",NIH,,"$655,113"
Ovarian Cancer,2012,NCI,1ZIABC011311-03,,Identification of genetic interactors of Brca2,"SHARAN, SHYAM",NIH,,"$329,752"
Ovarian Cancer,2012,NCI,1ZIABC011315-03,,Molecular characterization of endometrial cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$234,645"
Ovarian Cancer,2012,NCI,1ZIABC011353-03,,Development and validation of preclinical mouse model for serous ovarian cancer,"VAN DYKE, TERRY",NIH,,"$1,051,828"
Ovarian Cancer,2012,NIEHS,1ZIAES049032-16,,Environmental Exposure and DNA Damage,"TAYLOR, JACK",NIH,,"$1,131,566"
Ovarian Cancer,2012,NCI,1ZIASC006353-30,,Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"BRECHBIEL, MARTIN",NIH,,"$1,247,747"
Ovarian Cancer,2012,NCI,1ZIASC007263-20,,TRAIL-induced Cell Death in Breast Cancer Cells,"LIPKOWITZ, STANLEY",NIH,,"$238,803"
Ovarian Cancer,2012,NCI,1ZIASC009163-25,,Signal Transduction Therapy--Basic Science,"KOHN, ELISE",NIH,,"$435,505"
Ovarian Cancer,2012,NCI,1ZIASC009374-21,,Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,"KOHN, ELISE",NIH,,"$316,731"
Ovarian Cancer,2012,NCI,1ZIASC009375-20,,Signal Transduction Therapy--Clinical,"KOHN, ELISE",NIH,,"$527,886"
Ovarian Cancer,2012,NCI,1ZIEBC011136-04,,The CCRWalter Reed Army Medical Center Gynecologic Cancer Program Research Lab,"KOHN, ELISE",NIH,,"$39,592"
Ovarian Cancer,2012,NCI,1ZIHBC010470-10,,Bioinformatic Tools in Cancer Research,"BUETOW, KENNETH",NIH,,"$229,859"
Ovarian Cancer,2012,NCI,5U54CA118948-07,5384,Project 2 Landen_Rao,"MANNE, UPENDER",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$24,593"
Ovarian Cancer,2012,NCI,5U54CA118638-07,5404,BRCA1 Deficiency and Epithelial Ovarian Cancers,"RAO, VEENA",MOREHOUSE SCHOOL OF MEDICINE,GA,"$133,008"
Ovarian Cancer,2012,NCI,5P01CA154292-02,5435,Risk Assessment in Community Practice: Developing Better Models,"KERLIKOWSKE, KARLA",GROUP HEALTH COOPERATIVE,WA,"$557,770"
Ovarian Cancer,2012,NCI,5P30CA015704-38,5475,THERAPEUTIC MANUFACTURING,"HARTWELL, LELAND",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$552,470"
Ovarian Cancer,2012,NIAID,1ZIAAI001038-05,,Mechanisms of Antitumor Action of Human Interferon,"ZOON, KATHRYN",NIH,,"$99,866"
Ovarian Cancer,2012,NCI,261201200053C-0-0-1,,OTHER FUNCTIONS - A NOVEL PET PROBE FOR USE IN CANCER DIAGNOSTICS,"ESTERBY, MELISSA","SOFIE BIOSCIENCES, LLC",CA,"$250,000"
Ovarian Cancer,2012,NCI,261201200088C-0-0-1,,Homogeneous Nanoparticle-Based Assays for Protease Detection,"SOBEK, DANIEL","ZYMERA, INC.",CA,"$997,365"
Ovarian Cancer,2012,NCI,261201200092C-0-0-1,,OTHER FUNCTIONS TAS:: 750849 REFORMULATION OF CANCER THERAPEUTICS USING NANOTECH,"MCCONATHY, WALTER",LIPOMEDICS LTD,,"$191,326"
Ovarian Cancer,2012,NCI,261201000140C-5-0-2,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"GLASSER, SALLY",CANCER PREVENTION INSTIT OF CALIFORNIA,CA,"$113,271"
Ovarian Cancer,2012,NCI,261201000025C-7-0-3,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"WARD, KEVIN",EMORY UNIVERSITY,GA,"$58,849"
Ovarian Cancer,2012,NCI,261201000032C-9-0-3,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"LYNCH, CHARLES",UNIVERSITY OF IOWA,IA,"$50,827"
Ovarian Cancer,2012,NCI,261201000033C-7-0-4,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"WIGGINS, CHARLES",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$23,070"
Ovarian Cancer,2012,NCI,261201000034C-7-0-5,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"WEST, DEE",PUBLIC HEALTH INSTITUTE,CA,"$162,786"
Ovarian Cancer,2012,NCI,261201000037C-6-0-3,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"GOODMAN, MARC",UNIVERSITY OF HAWAII AT MANOA,HI,"$30,917"
Ovarian Cancer,2012,NCI,261201000035C-8-0-4,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"DEAPEN, DENNIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$119,148"
Ovarian Cancer,2012,NCI,261201000029C-9-0-4,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"SCHWARTZ, STEPHEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$73,114"
Ovarian Cancer,2012,NCI,261201000030C-8-0-3,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"CHEN, VIVIEN",LOUISIANA STATE UNIV HSC NEW ORLEANS,LA,"$64,132"
Ovarian Cancer,2012,NCI,261201000031C-8-0-4,,Patterns of Care (POC) Quality of Care Dx Yr 2011,"TUCKER, THOMAS",UNIVERSITY OF KENTUCKY,KY,"$106,858"
Ovarian Cancer,2012,NCI,1ZIACP010126-17,,Hormone-Related Cancers,"BRINTON, LOUISE",NIH,,"$4,518,164"
Ovarian Cancer,2012,NCI,1ZIACP010128-17,,Therapeutic and Diagnostic Factors as Related to Cancer Risk,"BRINTON, LOUISE",NIH,,"$917,223"
Ovarian Cancer,2012,NCI,1ZIACP010144-14,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"GREENE, MARK",NIH,,"$5,215,430"
Ovarian Cancer,2012,NCI,1ZIACP010145-13,,Intervention Trials in Persons at Increased Genetic Risk of Cancer,"GREENE, MARK",NIH,,"$1,567,046"
Ovarian Cancer,2012,NCI,1ZIACP010152-13,,PLCO Trial Etiologic and Early Marker Study,"HOOVER, ROBERT",NIH,,"$2,050,613"
Ovarian Cancer,2012,NCI,1ZIACP010182-10,,Epidemiologic Field Studies,"GAIL, MITCHELL",NIH,,"$446,334"
Ovarian Cancer,2012,NCI,1ZIACP010184-10,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$1,838,536"
Ovarian Cancer,2012,NCI,1ZIACP010187-08,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$269,589"
Ovarian Cancer,2012,NCI,1ZIACP010188-08,,Risk prediction methods,"GAIL, MITCHELL",NIH,,"$678,702"
Ovarian Cancer,2012,NCI,1ZIACP010207-03,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$840,647"
Ovarian Cancer,2012,NHGRI,1ZIAHG000120-16,,The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer,"BRODY, LAWRENCE",NIH,,"$89,335"
Ovarian Cancer,2012,NHGRI,1ZIAHG200323-08,,Genomic and Functional Analyses of Regulatory Regions in Vertebrate Sequences,"ELNITSKI, LAURA",NIH,,"$904,690"
Ovarian Cancer,2012,NHGRI,1ZIEHG200353-05,,NHGRI/DIR Genetic Counseling Training Program,"MCBRIDE, COLLEEN",NIH,,"$1,159,765"
Ovarian Cancer,2012,NCI,261201000024C-8-0-3,,Patterns of Care (POC) Quality of Care Dx Yr 2011,NO PI IDENTIFIED,CONNECTICUT STATE DEPT OF PUBLIC HEALTH,CT,"$38,700"
Ovarian Cancer,2012,NCI,ACN12013001-1-0-1,,EDRN Quantitative Verification of Ovarian Cancer Protein Biomarkers by Mass Spect,NO PI IDENTIFIED,NIH,,"$149,000"
Ovarian Cancer,2012,NCI,261200800001E-51-0-102,,Biospecimen Collection Proteomic,NO PI IDENTIFIED,"SAIC-FREDERICK, INC.",MD,"$2,000,000"
